Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- 2012
Democratic aspects of recent developments in European and US biotech patenting
Minssen, Timo (Speaker)
5 Oct 2012Activity: Talk or presentation types › Lecture and oral contribution
Standing in the Shadows of Brüstle? – The effect of the CJEU judgment in Brüstle v. Greenpeace on European Patents, Stem Cell Research & Pharmaceutical R&D (presented to the Committee for Advanced Therapies (CAT) at the EMA, London): A presentation prepared for the Committee for Advanced Therapies (CAT) at the European Medicines Agency (EMA), London, UK.
Minssen, Timo (Speaker)
14 Sep 2012Activity: Talk or presentation types › Lecture and oral contribution
Hot topics in pharmaceutical competition law- recent European & US developments
Minssen, Timo (Lecturer)
17 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
International controversies over section 3 d of the Indian Patent Act
Minssen, Timo (Lecturer)
16 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
Recent Indian case law on compulsory licensing- The NATCO decision
Minssen, Timo (Lecturer)
16 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The Approval of Biosimilars in the US – novel guidelines and developments
Minssen, Timo (Lecturer)
15 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
Recent US decisions on the patent-eligibility of isolated DNA, diagnostic methods and dosage regimes: Copenhagen Summer University (CSU)
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The EPO’s plausibility approach and the industrial application requirement in biotech patenting
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The patent eligibility of human embryonic stem cell technology in Europe
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The patentability of personalized medicine in Europe - Dosage regimes and genetic diagnostic methods
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
ID: 16150437
Most downloads
-
4350
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2244
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2098
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published